Literature DB >> 21320997

Validation of plasma branched chain amino acids as biomarkers in Huntington disease.

Fanny Mochel, Sandra Benaich, Daniel Rabier, Alexandra Durr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21320997     DOI： 10.1001/archneurol.2010.358

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  13 in total

1.  Transcriptional control of amino acid homeostasis is disrupted in Huntington's disease.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-19       Impact factor: 11.205

2.  Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease.

Authors:  Samantha Molsberry; Kjetil Bjornevik; Katherine C Hughes; Zhongli Joel Zhang; Sarah Jeanfavre; Clary Clish; Brian Healy; Michael Schwarzschild; Alberto Ascherio
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

3.  Ataxin-2 (Atxn2)-Knock-Out Mice Show Branched Chain Amino Acids and Fatty Acids Pathway Alterations.

Authors:  David Meierhofer; Melanie Halbach; Nesli Ece Şen; Suzana Gispert; Georg Auburger
Journal:  Mol Cell Proteomics       Date:  2016-02-05       Impact factor: 5.911

4.  A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington's disease: looking for biomarkers.

Authors:  Jolanta Krzysztoń-Russjan; Daniel Zielonka; Joanna Jackiewicz; Sylwia Kuśmirek; Irena Bubko; Aneta Klimberg; Jerzy T Marcinkowski; Elżbieta L Anuszewska
Journal:  J Bioenerg Biomembr       Date:  2012-10-16       Impact factor: 2.945

Review 5.  What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease.

Authors:  Lukasz Przybyl; Magdalena Wozna-Wysocka; Emilia Kozlowska; Agnieszka Fiszer
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

6.  Metabolic disruption identified in the Huntington's disease transgenic sheep model.

Authors:  Renee R Handley; Suzanne J Reid; Stefano Patassini; Skye R Rudiger; Vladimir Obolonkin; Clive J McLaughlan; Jessie C Jacobsen; James F Gusella; Marcy E MacDonald; Henry J Waldvogel; C Simon Bawden; Richard L M Faull; Russell G Snell
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

7.  Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.

Authors:  Lauren M Byrne; Filipe B Rodrigues; Kaj Blennow; Alexandra Durr; Blair R Leavitt; Raymund A C Roos; Rachael I Scahill; Sarah J Tabrizi; Henrik Zetterberg; Douglas Langbehn; Edward J Wild
Journal:  Lancet Neurol       Date:  2017-06-07       Impact factor: 44.182

Review 8.  Divergent Metabolic Regulation of Autophagy and mTORC1-Early Events in Alzheimer's Disease?

Authors:  Mai A Shafei; Matthew Harris; Myra E Conway
Journal:  Front Aging Neurosci       Date:  2017-06-02       Impact factor: 5.750

9.  Metabolic profiling of presymptomatic Huntington's disease sheep reveals novel biomarkers.

Authors:  Debra J Skene; Benita Middleton; Cara K Fraser; Jeroen L A Pennings; Timothy R Kuchel; Skye R Rudiger; C Simon Bawden; A Jennifer Morton
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

10.  Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samples.

Authors:  Anastasios Mastrokolias; Rene Pool; Eleni Mina; Kristina M Hettne; Erik van Duijn; Roos C van der Mast; GertJan van Ommen; Peter A C 't Hoen; Cornelia Prehn; Jerzy Adamski; Willeke van Roon-Mom
Journal:  Metabolomics       Date:  2016-07-27       Impact factor: 4.290
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.